Literature DB >> 10600688

Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.

L Michalik1, W Wahli.   

Abstract

The peroxisome proliferator-activated receptors (PPARs) are fatty acid and eicosanoid inducible nuclear receptors, which occur in three different isotypes. Upon activator binding, they modulate the expression of various target genes implicated in several important physiological pathways. During the past few years, the identification of both PPAR ligands, natural and synthetic, and PPAR targets and their associated functions has been one of the most important achievements in the field. It underscores the potential therapeutic application of PPAR-specific compounds on the one side, and the crucial biological roles of endogenous PPAR ligands on the other.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600688     DOI: 10.1016/s0958-1669(99)00030-0

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  37 in total

Review 1.  Arachidonic acid as a bioactive molecule.

Authors:  A R Brash
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 2.  Significance of anti-inflammatory effects of PPARgamma agonists?

Authors:  G Rogler
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

3.  The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats.

Authors:  Borja García-Bueno; José L M Madrigal; Ignacio Lizasoain; María A Moro; Pedro Lorenzo; Juan C Leza
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

4.  Studies on induction of lamotrigine metabolism in transgenic UGT1 mice.

Authors:  U A Argikar; K Senekeo-Effenberger; E E Larson; R H Tukey; R P Remmel
Journal:  Xenobiotica       Date:  2009-11       Impact factor: 1.908

5.  Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.

Authors:  Raquel Grau; Carmen Punzón; Manuel Fresno; Miguel A Iñiguez
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

6.  Pioglitazone treatment following spinal cord injury maintains acute mitochondrial integrity and increases chronic tissue sparing and functional recovery.

Authors:  Samir P Patel; David H Cox; Jenna L Gollihue; William M Bailey; Werner J Geldenhuys; John C Gensel; Patrick G Sullivan; Alexander G Rabchevsky
Journal:  Exp Neurol       Date:  2017-03-30       Impact factor: 5.330

7.  Keratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells.

Authors:  Robert J Mason; Tianli Pan; Karen E Edeen; Larry D Nielsen; Feijie Zhang; Malinda Longphre; Michael R Eckart; Steven Neben
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

8.  Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?

Authors:  Utpal Sen; Suresh C Tyagi
Journal:  PPAR Res       Date:  2010-06-29       Impact factor: 4.964

9.  PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues.

Authors:  Valerio Costa; Maria Assunta Gallo; Francesca Letizia; Marianna Aprile; Amelia Casamassimi; Alfredo Ciccodicola
Journal:  PPAR Res       Date:  2010-09-08       Impact factor: 4.964

10.  PPARs: Nuclear Receptors Controlled by, and Controlling, Nutrient Handling through Nuclear and Cytosolic Signaling.

Authors:  Maria Moreno; Assunta Lombardi; Elena Silvestri; Rosalba Senese; Federica Cioffi; Fernando Goglia; Antonia Lanni; Pieter de Lange
Journal:  PPAR Res       Date:  2010-08-01       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.